Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Trans-spectral organic dye laser photocoagulation.

F A L'Esperance

    Transactions of the American Ophthalmological Society
    |January 1, 1985
    PubMed
    Summary

    The dye laser, using yellow to red wavelengths, shows promise for ocular defect photocoagulation. Its selective tissue coagulation minimizes damage, making it valuable for treating eye diseases.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    A refractive and histopathologic study of excimer laser keratectomy in primates.

    American journal of ophthalmology·1990
    Same author

    Experimental corneal studies with the excimer laser.

    Journal of cataract and refractive surgery·1989
    Same author

    Human excimer laser keratectomy. Short-term histopathology.

    Bulletin of the New York Academy of Medicine·1989
    Same author

    Human excimer laser lamellar keratectomy. A clinical study.

    Ophthalmology·1989
    Same author

    Historical aspects of ophthalmic lasers.

    Caduceus (Springfield, Ill.)·1989
    Same author

    Excimer laser instrumentation and technique for human corneal surgery.

    Archives of ophthalmology (Chicago, Ill. : 1960)·1989

    Area of Science:

    • Ophthalmology
    • Biomedical Optics
    • Laser Medicine

    Background:

    • Ocular defects require precise therapeutic interventions.
    • Photocoagulation is a key treatment modality for various eye conditions.
    • Limitations exist with current photocoagulation sources regarding wavelength specificity and tissue damage.

    Purpose of the Study:

    • To evaluate the potential of liquid organic dye lasers for ocular photocoagulation.
    • To determine if dye lasers are the preferred choice for treating ocular defects.
    • To assess the efficacy of specific dye laser wavelengths (yellow, orange, red) in ophthalmic applications.

    Main Methods:

    • Clinical research employing dye lasers (Rhodamine 6G and MD-631).
    • Utilizing yellow, orange, and red wavelengths for photocoagulation.
    • Assessing selective tissue coagulation and energy transmission through ocular media.

    Main Results:

    • Dye lasers demonstrate considerable promise for ocular photocoagulation.
    • High output power wavelengths are trans-spectrally available.
    • Selective coagulation of target tissue is achievable with minimal damage to surrounding healthy tissues.

    Conclusions:

    • The liquid organic dye laser is a strong candidate for treating numerous ocular defects.
    • Its ability to selectively coagulate tissue with minimal collateral damage is a significant advantage.
    • Dye laser photocoagulation systems offer valuable therapeutic potential for diverse ocular diseases.

    Related Experiment Videos